Clinical Study for Palliative/Preventive Treatment of Chronic Back Pain
CompletedNot applicableNCT05597189
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Randomized, controlled, double-blind, double-blind clinical trial, with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product) and single-center, to measure the efficacy of a botanical supplement on the prevention of non-joint pain.
Study details
- Official title
- Clinical Study of Palliative / Preventive Treatment of Chronic Back Pain by Taking a Dietary Supplement Based on Botanical Extracts
- Conditions
- Supplementation
- Back Pain
- Interventions
- Dietary supplement: Experimental product
- Other: Control product consumption
- Sponsor
- Universidad Católica San Antonio de Murcia
- Start date
- 2022-09-26
- Primary completion
- 2023-06-26
- Sex
- All
- Age range
- from 20 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Men and women between 20 and 65 years of age. * The subjects must have localized myofascial pain in the back area (cervical, dorsal and lumbar), with an evolution time of at least 3 months. * The pain must present an initial score of at least 30 mm in the pain evaluation by means of the VAS scale. * The pain must be episodic. * BMI 18.5 - 29.9 kg/m2. * Subjects should not be treated with narcotic drugs or steroidal anti-inflammatory drugs. steroidal anti-inflammatory drugs or immunosuppressants. Exclusion Criteria: * Severe or terminal illnesses. * Subjects with pain associated with trauma. * Subjects with pain associated with chronic conditions (rheumatoid arthritis, herniated discs, ankylosing herniated disc, ankylosing spondylitis, etc.). * Subjects with known allergy to any of the components of the investigational product. the investigational product. * Subjects undergoing physiotherapy treatment during the course of the study. development of the study. * Pregnant or lactating women. * Inability to understand the informed consent.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05597189